KEQU vs HNI

For growth investors, Kewaunee Scientific Corporation (KEQU) is the stronger pick with 18.

0% revenue growth year-over-year, versus 12. 4% for HNI Corporation (HNI). Kewaunee Scientific Corporation (KEQU) offers the better valuation at 9. 5x trailing P/E (23. 8x forward), making it the more compelling value choice. Analysts rate HNI Corporation (HNI) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Kewaunee Scientific Corporation (KEQU) is the cheapest at 9.

5x versus HNI Corporation at 31. 3x. On forward P/E, HNI Corporation is actually cheaper at 8. 6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Kewaunee Scientific Corporation (KEQU) delivered a total return of +202.

7%, compared to -7. 3% for HNI Corporation (HNI). Over 10 years, the gap is even starker: KEQU returned +138. 9% versus HNI's +9. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), HNI Corporation (HNI) is the lower-risk stock at 1.

07β versus Kewaunee Scientific Corporation's 1. 09β — meaning KEQU is approximately 2% more volatile than HNI relative to the S&P 500. On balance sheet safety, Kewaunee Scientific Corporation (KEQU) carries a lower debt/equity ratio of 76% versus 89% for HNI Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Kewaunee Scientific Corporation (KEQU) is pulling ahead at 18.

0% versus 12. 4% for HNI Corporation (HNI). On earnings-per-share growth, the picture is similar: Kewaunee Scientific Corporation grew EPS -40. 0% year-over-year, compared to -61. 5% for HNI Corporation. Over a 3-year CAGR, KEQU leads at 12. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Kewaunee Scientific Corporation (KEQU) is the more profitable company, earning 4.

7% net margin versus 1. 9% for HNI Corporation — meaning it keeps 4. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HNI leads at 8. 4% versus 7. 4% for KEQU. At the gross margin level — before operating expenses — HNI leads at 41. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, HNI Corporation (HNI) trades at 8.

6x forward P/E versus 23. 8x for Kewaunee Scientific Corporation — 15. 3x cheaper on a one-year earnings basis.

In this comparison, HNI (3.

7% yield) pays a dividend. KEQU does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, HNI Corporation (HNI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

07), 3. 7% yield). Both have compounded well over 10 years (HNI: +9. 3%, KEQU: +138. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (KEQU (Consumer Cyclical) and HNI (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: KEQU is a small-cap high-growth stock; HNI is a small-cap income-oriented stock. HNI pays a dividend while KEQU does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.